Professional Documents
Culture Documents
Department of Health
OFFICE OF THE SECRETARY
Manila
March 9, 1989
ADMINISTRATIVE ORDER
No. 62 s. 1989
Pursuant to Section 9 in relation to Section 6 (a) and 6 (d) of R.A. 6675 known as
“Generics Act of 1988”, and the pertinent provisions of R.A. 3720 known as “Food, Drugs
and Devices and Cosmetics
Cosmetics Act", as amended by Executive Order No. 175 s 1987, 1987, RA
5921 known as the Pharmacy Act and R.A. 4224 and R.A. 5946; R.A. 4419 known as the
Dental Act, R.A. 382 known as the Veterinary Act, and R.A. 6425 known as the
Dangerous Drug Act of 1972 as amended, the following rules and regulations are hereby
promulgated:
1.6 Drugs means (1) “articles recognized in the current official United States
Drugs means
Pharmacopoeia-National Drug Formulary (USP-NF), official Homeopathic
Pharmacopoeia of the United States, Official Philippine National Drug
Formulary, or any supplement to any of them, and (2) articles intended
for use to diagnosis, cure, mitigation, treatment or prevention of disease
in man or animals; and (3) articles (other than food) intended to affect the
structure or function of the body of man or animals; and (4) articles
intended for use as a component of any articles specified in clauses (1),
(2) or (3) but do not include devices or their components, parts or
accessories.
1.7 Drug product or medicine is the finished form that contains the active
ingredient(s), generally, but not necessarily in association with inactive
ingredients.
1.7.1 Prescription or ethical drugs are pharmaceutical products or drug
preparation that are to be dispensed only upon written order of a
validly-registered licensed physician, dentist or veterinarian for
the management or treatment of a condition or disease.
1.8.1 Prohibited drugs include “opium and the active components and
derivatives such as heroin and morphine; coca leaf and its
derivatives, principally cocaine, alpha and beta Eucoine,
hallucinogenic drugs, such as masculine, lysergic acid
diethylamide (LSD) and other substances producing similar
effects: Indian hemp and its derivatives; all preparations made
derivatives; all preparation made from any of the foregoing; and
other drugs, whether natural or synthetic, with the physiological
effects of a narcotic drug.”
1.8.2 Regulated drugs includes sleep-inducing sedatives, such as
secobarbital, Phenobarbital, barbital amobarbital and other drugs
which contain a salt or derivative of a salt of barbituric acid; any
salt, isomer or salt of an isomer, of amphetamine, such as
Benzedrine or denadrine and hypnotic drugs such as , or ay
other compound producing similar pharmacologic effects
4.2. Erroneous prescriptions shall be filled, but they shall also be kept
and reported to the nearest DOH office for appropriate action.
SECTION 5 Violations on the part of dispensers and outlets
5.2. Inaccurate dispensing i.e. dispensing a drug product which does not
meet the prescription as to any or all of the following: active
ingredient, dosage form and strength.
Any interested party may report any verifiable violation of these Rules
and Regulations to the nearest DOH office. the local DOH office is
responsible for giving notice to erring pharmacists/outlets and for
transmitting the report on violations to the Secretary of Health or the
fiscal's office for appropriate action.
The imposition of the above sanctions does not preclude the institution of
appropriate criminal proceedings pursuant to Section 12 of RA 6675
known as the Generics Act of 1988, RA 3720 known as "Foods, Drugs
and Devices and Cosmetics Act" as amended and R.A. 5921 known as
"Pharmacy Law" as amended, R.A. 6425 known as the Dangerous Drugs
Act of 1972 as amended and other relevant laws, by the regional health
office concerned, upon receipt of complaints or reports of violations.
SECTION 9 Timetable of Implementation
In order to give all affected parties adequate time for learning and
adjustment, the implementation of these Rules and Regulations shall be
in three phases, as follows:
From June 1, 1989 to August 31, 1989, the DOH shall monitor
voluntary compliance with the provisions of the Rules and
Regulations on Prescribing and Dispensing. During this period,
the associations of affected professionals are enjoined to
promote compliance in order to achieve a smooth transition to
the next phase of full implementation.
SECTION 12 Effectivity
This order shall take effect fifteen days after its publication in two newspapers of
general circulation.